Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology

Combination to bring germline and somatic testing, liquid biopsy and tissue genomic profiling onto a single platform to offer patients a full suite of cancer testing for risk, therapy optimization and personalized cancer monitoring Provides unrivaled br... Diagnostics, Oncology, Mergers & Acquisitions Invitae, ArcherDX, precision oncology
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news